Obesity is associated with elevated levels of inflammation and metabolic abnormalities
which are linked to CVD. The aim of the present study was to investigate whether long-chain …

BACKGROUND: Obesity is associated with elevated levels of inflammation and metabolic
abnormalities, with increased risk of developing insulin resistance, type 2 diabetes, stroke …

The current paradigms of prevention and treatment are unable to curb obesity rates, which
indicates the need to explore alternative therapeutic approaches. Obesity leads to several …

The increasing incidence of the metabolic syndrome (MetS), a combination of risk factors
before the onset of CVD and type 2 diabetes, encourages studies on the role of functional …

Background: Postprandial dyslipidaemia occurs in obesity and insulin resistance (IR), and is
associated with an increased risk of developing cardiovascular disease. We have recently …

Few trials have evaluated the metabolic effects and health outcomes of lowering dietary n-6
PUFA. The objectives of the present paper were (1) to report the methods employed to lower …

There is increasing interest in the potential chronic beneficial effects of dietary n-3 PUFA on
the metabolic syndrome (MetS) and associated cardiovascular complications. We have …

Recent studies have indicated that omega-3 (n3) polyunsaturated fatty acids (PUFAs)
decrease adipose tissue inflammation in rodents and in morbidly obese humans. We …

Obesity has been linked with low levels of ω-3 fatty acids. Generally, intervention studies
have failed to establish benefits of supplementation with ω-3PUFA in reducing body weight …

Background: Replacing SFAs with vegetable PUFAs has cardiometabolic benefits, but the
effects on liver fat are unknown. Increased dietary n-6 PUFAs have, however, also been …